Despite of important efforts made in the recent time, little progress has been made to better characterise high-risk PC populations and to identify genomics-based markers for its early diagnosis. PC rates continue to rise, and this disease is becoming a real public health problem in the Westernised world. International and multidisciplinary strategies to identify new markers and properly validate the promising ones are urgently needed to implement cost-efficient primary and secondary prevention interventions in PC.
Muin J. Khoury, Colleen M. McBride, Sheri D. Schully, John P A Ioannidis, W Feero, A. Cecile J.W. Janssens, Marta Gwinn, Denise G. Simons‐Morton, Jay M. Bernhardt, Michele Cargill, Stephen J. Chanock, George M. Church, Ralph J. Coates, Francis S. Collins, Robert T. Croyle, Barry R. Davis, Gregory J. Downing, Amy DuRoss, Susan Hatters Friedman, Mitchell H. Gail, Geoffrey S. Ginsburg, Robert C. Green, Mark H. Greene, Philip Greenland, Jeffrey R. Gulcher, Andro Hsu, Kathy Hudson, Sharon L. R. Kardia, Paul L. Kimmel, Michael S. Lauer, Amy M. Miller, Kenneth Offit
Manish Roorkiwal, C. Bharadwaj, Rutwik Barmukh, G. P. Dixit, Mahendar Thudi, Pooran M. Gaur, S. K. Chaturvedi, Asnake Fikre, Aladdin Hamwieh, Shiv Kumar, Supriya Sachdeva, Chris O. Ojiewo, Bunyamin Tar’an, Nigusie Girma Wordofa, Narendra Pratap Singh, Kadambot Siddique, Rajeev K. Varshney
Discussion(0)
No comments yet. Be the first to comment.